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Ethanolic, cold water and hot water extracts of the root of Synclisia scabrida were tested, by the agar-
well diffusion and macro-broth methods, for activity against clinical and typed strains of Escherichia 
coli, Salmonella sp., Staphylococcus aureus, Pseudomonas aeruginosa, Proteus sp. and Bacillus 
subtilis. The ethanolic extract was bactericidal at the minimum inhibitory concentration (MIC) against 8 
of the 10 test organisms (MIC, 3.125 to 12.50 mg/ml and MBC, 3.125 to 25.00 mg/ml).  The cold water 
extract was bactericidal against E. coli (clin) and B. subtilis ATCC 6051 strains and bacteriostatic 
against 5 others while the hot water extract was bacteriostatic against 2 of the organisms at MIC. Three 
column chromatographic fractions of the crude ethanolic extract, Fss-1, Fss-2, and Fss-3, were active 
against 5 to 8 of the 10 test bacterial strains.  Fss-3 was bacteriostatic against the Proteus sp. (clin), 
which was not susceptible to the crude ethanolic extract. Conversely, the crude ethanolic extract was 
bactericidal against P. aeruginosa ATCC 10145 to which none of the fractions showed activity. Thus, 
the results justify the folklore application of extracts of S. scabrida in treatment of bacterial 
gastroenteritis among other diseases. 
 





Synclisia scabrida (Meirs) of the family, 
Menispermaceae, is a common shrub of tropical Africa 
present in southern Nigeria, Cameroon, Gabon, 
Democratic Republic of Congo and Angola (Hutchison 
and Dalziel, 1954). It is commonly used as fodder for 
domestic animals but also has a folklore reputation as 
herbal remedy for lower abdominal pains, listlessness, 
mental strain and certain sexually transmitted diseases. 
Aqueous decoctions of the leaves, stem bark and root 
have been prescribed in ethnomedicine in cases of 
gastroenteritis. Sokomba et al. (1986) detected two 
alkaloids in the water extract and five in the ethanolic 
extract of the leaves; and reported hot ethanol extracts of  
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these observations in view, the study reported here set 
out to validate the folklore use of whole root extracts of 
the plant (in water or alcohol) among the Igbos of 
southeastern Nigeria to treat gastrointestinal disorders. 
Thus, ethanolic and water (hot and cold) extracts of 
whole root preparations of S. scabrida were evaluated for 
antibacterial activity against isolates of locally diagnosed 
aetiologic agents of gastroenteritis and typed bacterial 
strains used as controls.  
 
 




Whole roots of the plant, taxonomically authenticated by A. O. 
Ozioko of Botany Department, University of Nigeria, Nsukka as 
Synclisia scabrida Meirs (Igbo: Uzi), was obtained from the herbal 
garden of Chief Nwaenyi Ossai, a traditional healer from Orba, 






was deposited in the herbarium of the Botany Department, 
University of Nigeria, Nsukka. 
 
 
Preparation and phytochemical analysis of plant extracts 
 
The whole root samples, dried in the dark at room temperature, 
were pulverized with a mechanical grinder. A 50 g weight of the 
powder was extracted in cold water, hot water, or ethanol (BDH) 
and the extract filtered, dried and sterilized as described by Okeke 
et al. (2001). Phytochemical screening of the reconstituted extract 
was done using standard phytochemical methods (Harbone, 1973; 
Evans, 1989).The concentrations of the metabolites detected were 
expressed as low (+), moderate (++) or high (+++) depending on 
the intensity of the colour reaction. 
 
 
Test bacterial strains 
 
Local bacterial isolates from cases of gastrointestinal disorder, 
namely, Escherichia coli (clin), Salmonella sp (clin), Proteus sp 
(clin), Staphylococcus aureus (clin) and Pseudomonas aeruginosa 
(clin) were obtained from the Medical Diagnostic Laboratory, 
Department of Microbiology, University of Nigeria, Nsukka.  The 
Department of Veterinary Medicine and Pathology of the above 
University provided Salmonella kintambo SSRL 113, a typed local 
clinical isolate. The Bioresources Development and Conservation 
Project (BDCP), Nsukka supplied the remaining typed strains – E. 
coli ATCC 11775, S. aureus ATCC 12600, P. aeruginosa ATCC 
10145 and Bacillus subtilis ATCC 6051. All test bacterial strains 
were purified by streaking and re-isolating three successive times 
on Mueller Hinton agar, MHA (Oxoid). Identity of each strain was 




Testing extracts for antibacterial activity 
 
The inoculum size of each test strain was standardised at 5 x 105 
cfu/ml using McFarland Nephelometer according to the National 
Committee for Clinical Laboratory Standards (NCCLS, 1993, Okeke 
et al., 2001). A 1.0 ml volume of the standardized bacterial 
suspension was evenly spread on MHA with a sterile glass 
spreader. After allowing the inoculum to dry at room temperature, 6 
mm-diameter wells were bored in the agar with sterile cork-borer. 
Each extract was checked for antibacterial activity by introducing 
100 µl of a 25 mg/ml concentration into triplicate wells. The plates 
were allowed to stand at room temperature for 1 h for extract to 
diffuse into the agar and then incubated at 37°C for 18 h in a 
humidified incubator. Subsequently, the plates were examined for 
bacterial growth inhibition and the inhibition zone diameter (IZD) 
measured to the nearest mm. Only extracts showing measurable 
IZD in this preliminary screening were further studied. 
 
 
Determination of MIC and MBC 
 
The minimum inhibitory concentration (MIC) was determined by 
both agar well diffusion (Okeke et al., 2001) and macro-broth 
dilution (NCCLS, 1993) methods. A 100 µl volume of two-fold serial 
dilutions of the extracts reconstituted in distilled water (cold and hot 
water extracts) or 5% DMSO (ethanolic extract) was introduced into 
triplicate wells in MHA plates pre-inoculated with test bacterial 
strain. The extracts were allowed to diffuse into the MHA at room 
temperature before incubation at 37°C for 18 h. 




For macro-broth dilution assay, the reconstituted extract was 
serially diluted two-fold in Mueller Hinton broth (MHB, Oxoid) 
medium. Duplicate tubes of each dilution were inoculated with 5 x 
105 cells (cfu) of the test bacterial strain and cultures incubated in a 
water bath at 37°C for 18 h. Two-fold serial dilutions of ciprofloxacin 
(µg/ml concentrations) were included in each experiment as 
controls. MIC was taken as the lowest concentration of extract or 
drug showing clear zone of inhibition in the agar-well diffusion 
technique and as the highest dilution (least concentration) of extract 
or drug showing no detectable growth in the macro-broth assay. 
For determination of minimum bactericidal concentration (MBC), 
0.1 ml of culture medium was aspirated from each macro-broth 
assay tube showing no apparent growth and sub-cultured in fresh 
MHA. After incubation at 37°C for 24 h, the least concentration 
showing no visible growth on subculture was taken as the MBC.  
MIC index was computed from the values of MIC/MBC determined 
by the agar-well diffusion and macro-broth assays, respectively. 
 
 
Determination of rate of kill 
 
Rate of kill was determined by assay of bacterial cell-death time 
and was done for ethanolic extract against E. coli (clin) only. 
Approximately 5 x 105 cfu of test bacterial strain was introduced into 
10 ml of MHB containing 3.125, 6.25, 12.5 or 25.0 mg/ml (i.e. 
½MIC, 1MIC, 2MIC or 4MIC) of extract. The controls consisted of 
two sets of duplicate cultures, one without extract or drug (negative 
control) and the other supplemented with 0.5 µg/ml of ciprofloxacin 
(positive control). All experiments were incubated in a shaker water 
bath at 37°C. At 30 min intervals, 0.2 ml of sample was withdrawn, 
diluted in ten-fold series and 0.2 ml of each dilution plated in 
triplicate on MHA. After 24 h incubation at 37°C, emergent bacterial 
colonies were counted and compared with the count of the culture 
control without extract or drug. The results were expressed as 





The brine shrimps used were obtained by hatching 5 mg of eggs of 
Artemia salina (Interpet Ltd., England) in natural seawater after 
incubation at about 29°C for 48 h. The larvae (nauplii) were allowed 
another 48 h in seawater to ensure survival and maturity before 
use. 
Three doses of plant extract (2, 20, and 200 µg/ml), in 5% DMSO 
and/or seawater, were tested.  Each extract preparation was 
dispensed into clean test tubes in 10-ml volumes and tested in 
triplicates. To each tube was added 10 brine shrimps and the 
experiment incubated at 29°C for 24 h in a water bath, after which 
each tube was examined and the surviving brine shrimps counted 
and recorded. The control consisted of 10 brine shrimps per tube in 
5% DMSO and or seawater without plant extract. The 50% lethal 






The yield of dry extracts from 50 g powdered plant 
material and the pH of the reconstituted preparations are 
shown in Table 1. More extracts were obtained by weight 
with hot water (24.7%) and cold water (11.27%) than with 
ethanol (4.53%). Whereas the water extracts had acid pH 
(4.6 and 4.7, respectively)   the  ethanolic  extract  had   a  




Table 1.  Yield of S. scabrida constituents extracted by ethanol, cold- and 
hot-water maceration, respectively. 
                               
Extract Yield (g) Yield (%) pHc 
Cold water 5.63 11.27a 4.7 
Hot water 12.35 24.70a 4.6 
Ethanol 2.27 4.53a 7.2 
 Fractions of ethanolic extract 
Fss-1 1.12 32.00b 4.5 
Fss-2 0.36 10.30b 4.7 
Fss-3 0.28 8.00b 3.8 
 
                                                                                    aYield as percentage of 50 g of plant material. 
                                                                                     bYield as percentage of 3.5 g of ethanolic extract. 
                                                                                      cpH of wet extract before drying. 
 
 
                  Table 2.  Phytochemical components of whole root extracts of S. scabrida. 
 
Extracts Fractions of ethanol extract  
Plant constituent Cold water Hot water Ethanol Fss-1 Fss-2 Fss-3 
Alkaloid +++ +++ +++ ++ - - 
Flavonoid - - ++ + + ++ 
Tannin  +++ ++ ++ + - - 
Saponin  +++ +++ + ++ ++ ++ 
Glycosides  - - ++ - - ++ 
Anthroquinone  - - - ND ND ND 
Carbohydrate  +++ ++ +++ + + + 
Protein + ++ + ND ND ND       




neutral pH of 7.2. However, column chromatographic 
fractions of the ethanolic extract, Fss-1, Fss-2, and Fss-3 had 
acid pH (3.8-4.7) and 32.0, 10.3 and 8.0% yields, 
respectively. 
Alkaloids, flavonoid, tannin, saponin, glycosides, 
carbohydrate and protein were the phytochemicals 
detected in varying proportions in the extracts as well as 
in the fractions of the ethanolic extract. Protein, detected 
at low concentration (+) in the crude ethanolic extract was 
not detected at all in any of the three fractions. 
Anthroquinone was not detected in any sample (Table 2). 
Overall, 8 out of the 10 (80%) test strains were 
susceptible to the ethanolic extract, 7 (70%) to the cold 
water extract and only 2 (20%) to the hot water extract. 
The highest inhibition zone diameter, IZD (29.00±0.20 
mm) was observed also with ethanolic extract against B. 
subtilis ATCC 6051 followed by 27.25±1.50 mm activity of 
the same extract against S. aureus (clin).  Cold water 
extract ranked second with IZD of 27.0±1.0 mm against 
B. subtilis 6051. Both the cold water and ethanolic 
extracts each produced IZD of 24.5±1.50 mm against 
Salmonella sp (clin). The least IZD (5.5±0.2 mm) was 
achieved with hot water extract against E. coli (clin). P. 
aeruginosa (clin) and Proteus sp (clin) were not 
susceptible to activity of any of the extracts while P. 
aeruginosa ATCC 10145 was sensitive to the ethanolic 
extract only (IZD, 5.90 ± 0.10 mm; MIC, 12.50; MBC, 
12.50 and MIC/MBC index 1.0).  Ciprofloxacin was active 
against 9 of the 10 (90%) test bacterial strains with IZD 
ranging from 7.05±0.35 mm against P. aeruginosa (clin) 
to 31.85±0.25 mm against E. coli ATCC 11775 (Table 3).  
Thus, for the bacterial strains which showed susceptibility 
to the extracts, P. aeruginosa was sensitive to 1 out of 3 
(33.33%) of the extracts, E. coli (clin) and B. subtilis to all 
(100%) and the rest, each sensitive to 2 (66.67%) of the 
extracts (Table 3). 
The MIC and MBC values of the cold water extracts 
(0.195-6.250 mg/ml and 0.390-3.125 mg/ml, respectively) 
were lower than those of the ethanolic extract (3.125-
12.50 mg/ml, 3.125-25.00 mg/ml) The MIC and MBC 
values of ciprofloxacin were 0.625-80.00 µg/ml and 
1.250-80 µg/ml, respectively (Table 3). 
Table 4 shows the antibacterial activity of the column 
chromatographic fractions of the crude ethanolic extract. 
The fractions, Fss-1, Fss-2 and Fss-3 produced IZD ranges of 
3.50±0.50  to  29.60±0.50 mm,  7.20±0.01  to  11.50±1.00  




    Table  3. Susceptibility of test bacterial strains to whole root extracts of S. scabrida. 
 
Antibacterial Activity 















































16.5±0.55 3.125 3.125 1.00 5.5±0.2
0 
3.125 0.00 0.00 17.5±0.50 12.50 25.00 0.5 24±1.0 10.00 10.00 1.0 3/3 (100.00) 
E. coli ATCC 
11775 
20.25±1.25 3.125 0.00 0.00 0.00 0.00 0.00 0.00 10.90±0.90 12.50 12.50 1.0 31.85±0.25 10.00 20.00 0.5 2/3 (66.67) 
Salmmella  sp. 
(clin) 
24.5±1.50 6.250 0.00 0.00 0.00 0.00 0.00 0.00 24.5±1.50 6.250 6.250 1.0 31.50±0.5 2.50 5.00 0.5 2/3 (66.67) 
S.  kintambo 
SSRL113 
17.10±0.70 3.125 0.00 0.00 0.00 0.00 0.00 0.00 19.±1.40 3.125 3.125 1.0 21.80±0.00 1.250 1.250 1.0 2/3 (66.67) 
Staphylococcus 
aureus (clin) 
16.0±1.0 1.560 0.00 0.00 0.00 0.00 0.00 0.00 27.25±0.25 6.25 12.50 0.5 21.25±0.25 10.00 10.00 1.0 2/3 (66.67) 
S. acureus 
ATCC 12600 
9.0±0.4 0.780 0.00 0.00 0.00 0.00 0.00 0.00 22.50±0.50 12.50 12.50 1.0 26.85±0.45 2.50 5.00 0.5 2/3 (66.67) 
Pseudomonas 
aeruginosa(clin) 
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.05±0.35 80.00 0.00 0.00 0/3 (0.00) 
Ps.aeruginosa  
ATCC 10145 
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.90±0.10 12.50 12.50 1.0 0.00 0.00 0.00 0.00 1/3 (33.33) 
Protens sp (clin) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 17.0±1.0 0.625 1.250 0.5 0/3 (0.00) 
Bacithus subtilis 
ATCC 6051 
27.0±1.0 0.195 0.390 0.50 13.6∀0.01 3.125 0.00 0.00 29.00±1.00 3.125 6.250 0.5 9.0±1.0 80.00 80.00 1.0 3/3 (100.00) 
Proportion 
Susceptible (%) 
7/10 (70.00) 2/10 (20.00) 8/10 (80.00) 9/10 (90.00)  
- 
    








                      Table  4. Antibacterial activity of column chromatographic fractions of whole root ethanolic extract of S. scabrida. 
 
 






                                                                                                       Antibacterial Activity 
Fraction 1 (Fss-1) Fraction 2 (Fss-2) Fraction 3 (Fss-3) 
 
 
Test Bacterial strains IZD 
(mm) 
 



























Escherichia coli (clin) 12.50±0.50 25.00 0.00 0.00 0.00±0.0
0 
0.00 0.00 0.00 12.50±0.00 3.125 6.250 0.50 2/3 (66.67) 
Escherichia coli ATCC 1175 8.70±0.55 50.00 0.00 0.00 7.20±0.1
0 
3.125 0.00 0.00 10.00±1.00 6.250 6.250 1.00 3/3 
(100.00) 
Salmmella  sp. (clin) 15.00±0.0
0 
3.125 12.50 0.25 9.50±0.0
0 
6.250 0.00 0.00 6.00±0.55 3.125 0.00 0.00 3/3 
(100.00) 
S.almonella  kintambo 
SSRL113 
3.50±0.50 6.250 0.00 0.00 11.50±1.00 12.50 0.00 0.00 18.00±1.00 3.125 0.00 0.00 3/3(100.00) 
S.taphylococcus aureus 
(clin) 
5.00±1.00 50.250 0.00 0.00 0.00 0.00 0.00 0.00 5.00±0.50 25.00 0.00 0.00 2/3 (66.67) 
Staphylococcus  acureus 
ATCC 12600 
17.50±0.00 3.125 6.250 0.50 0.00 0.00 0.00 0.00 7.00±0.50 3.125 0.00 0.00 2/3 (66.67) 
Pseudomonas aeruginosa 
(clin) 
ND ND ND ND 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 (0.00) 
Pseudomonas aeruginosa 
ATCC 10145 
0.00±0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 (0.00) 
Protens sp (clin) 0.00±0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.20±1.00 6.250 0.00 0.00 1/3 (33.33) 
Bacithus subtilis ATCC 
6051 
29.60±0.50 3.125 0.00 0.00 8.00±1.00 6.250 0.00 0.00 12.50±0.50 6.250 0.00 0.00 3/3 
(100.00) 
Proportion Susceptible (%) 7/9 (77.80) 4/10 (40.00) 7/10 (70.00) - 




                     Table 5.  Rate of kill of E. coli (clin) at different concentrations (multiples of MIC) of the S. scabrida ethanol extract. 
 
Viable cell reduction per exposure time (log10) Concentration of Extract (mg/ml) 
30 min 60 min 90 min 120 min 
0.5MIC (3.125) +0.10 +0.37 +0.41 +0.43 
1.0MIC (6.25) -0.40 0.63 -0.70 0.73 
2.0MIC (12.50) -0.37 -0.85 -3.70 -3.70 
4.0MIC (25.6) -3.70 -3.70 -3.70 -3.70 
0.0MIC (Negative control) +0.23 +0.38 +0.41 +0.43 
Ciprofloxacin (0.8 µg/ml) >-5.80 >-5.80 >-5.80 >-5.80 
                    
 
 
                  Table  6.  Evaluation of S. scabrida whole root extracts for cytotoxicity by the Brine Shrimp lethality assay method. 
 




200 ppm 20 ppm 2 ppm 
50% lethal concentration 
(LC50, mg/ml) 
Cold water 100.00 60.00 46.67 114.169 
Hot water 75.00 40.00 0.00 202.068 





mm and 3.20±1.00 to 18.00±1.00 mm, respectively. 
Although the crude ethanolic extract was active against 
P. aeruginosa ATCC 10145 (IZD, 5.9±0.10; MIC, 12.50 
and MIC/MBC index, 1.0), no activity was observed with 
any of the partially purified fractions (Fss-1, Fss-2 or Fss-3) 
against any of the two Pseudomonas strains. Conversely, 
the crude ethanolic extract showed no activity against 
Proteus sp (clin) but Fss-3 exhibited activity against this 
strain (IZD, 3.20±1.00; MIC, 6.250).  
Table 5 shows net log10 increase (+) or reduction (-) in 
viable E. coli (clin) cell count (cfu/ml) following exposure 
to varying concentrations of extracts/drug for different 
periods of time (min). There was net growth of the test 
bacterial strain following exposure to 3.125 mg/ml 
concentration (1/2 MIC) of the ethanolic extract for 30-
120min. However, 6.25 mg/ml (1 MIC), 12.5 mg/ml 
(2MIC) and 25.0 mg/ml (4MIC) produced the reductions 
in bacterial cell counts at the various exposure time 
shown in the table. The 0.8 µg/ml concentration of 
ciprofloxacin killed all the bacterial cells within 30 min of 
exposure. The 50 percent lethal concentration, LC50, 
calculated for each extract (against the brine shrimps), is 





The low yield of plant extracts may reflect the low 
efficiency of the cold maceration method compared with 
the alternative, the soxhlet extraction (Ibrahim et al., 
1977). Cold maceration was adopted in order to conform 
to the traditional method of medicinal plant preparation. It 
is conceivable that the low yield inherent in this extraction 
method necessitates the large volumes (250 – 400 ml of 
aqueous or 20-50 ml of ethanol preparations, sometimes 
taken thrice daily) prescribed in the traditional herbal 
treatments. Such large volumes may be required to 
deliver the effective dose of the active principle(s). 
Alkaloid, tannin, saponin, carbohydrate and protein 
were present in all extracts but in varying proportions 
while authroquinone was not detected in any extract. 
Antimicrobial properties of several plant extracts have 
been attributed to secondary metabolites such as some 
of these (Watt and Breyer-Brandwijk, 1967; Leven et al., 
1979). The significance of the levels and types of 
metabolite present vis-à-vis the antibacterial activity 
detected in each extract is not known. The disparity in 
antibacterial activity between the cold and hot water 
extracts in spite of the similarity in the type of secondary 
metabolites they contained may suggest heat-inactivation 
of the components in the hot water extract. 
The spectra of antibacterial activity exhibited by the 
cold-water and ethanolic extracts (70% and 80%, 
respectively) are ethnomedicinally significant because 
these two are the traditional forms in which S. scabrida is 
prepared and dispensed.  The cold water extract, which 
apparently exhibits a lower MIC value, is the form 
preferred in treatment of gastrointestinal disorders while 
the ethanolic preparation of the root, particularly, is 
applied in treatment of sexually transmitted diseases 
(STD). 
Column chromatographic separation would, at least, 
achieve a partial purification. Thus, appearance of 
antibacterial activity in the three fractions (Fss-1,  Fss-2  and  
 




Fss-3) of the ethanolic extract may suggest presence of 
more than one antibacterial constituent in each extract. 
However, the metabolites detected in the crude extract 
were either present in one fraction of the partially purified 
sample (e.g. alkaloid in Fss-1 and glycoside in Fss-2) or 
they were redistributed in the three fractions (e.g. 
flavonoid and saponin). It is not possible at this stage to 
know whether the putative active components act 
synergistically, additively or antagonistically. The 
observation that the crude ethanolic extract had no 
antibacterial activity against Proteus sp (clin), which was 
susceptible to Fss-3 activity (IZD, 3.20±1.00mm; MIC, 
6.250mg/ml), is remarkable. This observation was 
reproduced in three repeat experiments and may indicate 
antagonism between certain components of the crude 
extract. Therefore, purification may be required to 
potentate such constituents. Conversely, the antibacterial 
activity of the crude ethanolic extract against P. 
aeruginosa ATCC 10145 was apparently lost following 
partial purification by column chromatography, thus, 
supporting the suggestion of Kafaru (1994) that crude 
preparations could, sometimes, exhibit higher efficacy 
than pure plant substances. Both results considered 
together, would suggest that the effect of purification on 
anti-bacterial activity of plant constituents would depend 
on the type of interactions (antagonism, synergy or 
additivity) occurring between the plant constituents. 
The rate of kill of test bacterial cells varied with 
concentration of extract, duration of exposure and even 
the bacterial strain tested (the latter result not shown). 
That half the MIC (3.125 mg/ml) did not inhibit growth of 
E. coli (clin) while the MIC (6.25 mg/ml) and its multiples 
(12.50 mg/ml and 25.0 mg/ml) did, confirm the reliability 
of the MIC determination. Overall, the results indicate that 
the extracts were potent antibacterial preparations, at 
least, in vitro.  In vivo evaluation may be required to 
ascertain that active but non-toxic concentrations of 
extracts may be absorbed and may remain bioactive for 
the time duration required to completely kill the pathogen. 
The brine shrimps lethality assay showed the ethanolic 
extract to be more cytotoxic or more bioactive, killing the 
shrimps at lower concentration (LC50=36.57 µg/ml) than 
the cold water extract (LC50=114.169  µg/ml) or the hot 
water extract (LC50 =>202.068 µg/ml).  This assay 
method is used to screen plant extracts generally for 
bioactive compounds (McLaughlin et al., 1991).  
Bioactive compounds are pharmacologically toxic at 
higher concentrations, hence the application of the brine 
shrimp method in testing for cytotoxicity (Meyer et al., 






extrapolated to mean toxicity to intact laboratory animals 
or man because the latter have more efficient 
mechanisms for breaking down similar substances found 
in foods of plant origin.   
In summary, the in vitro activity of S. scabrida cold 
water and ethanolic extracts against recognized 
enteropathogens, E. coli and Salmonella sp, as well as 
other bacterial strains often associated with non-
gonococcal urethritis may provide a scientific justification 
for the traditional (folklore) use of the plant in treatment of 
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